Company performance
Add to research
Current Price
as of Apr 17, 2025$2.19
P/E Ratio
N/A
Market Cap
$130.76M
Description
Add to research
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Metrics
Add to research
Overview
- HQLexington, MA
- SectorHealth Technology
- IndustryBiotechnology
- TickerALDX
- Price$2.19+8.96%
Trading Information
- Market cap$130.76M
- Float97.10%
- Average Daily Volume (1m)3,514,053
- Average Daily Volume (3m)1,478,773
- EPS-$0.94
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$55.85M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$59.87M
- EV$210.98M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B1.84
- Debt/Equity21.55
Documents
Add to research
SEC Filings
Factset Street Account